TCR2 Therapeutics Inc. (TCRR): Price and Financial Metrics


TCR2 Therapeutics Inc. (TCRR): $2.30

0.11 (+5.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TCRR to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

TCRR Stock Price Chart Interactive Chart >

Price chart for TCRR

TCRR Price/Volume Stats

Current price $2.30 52-week high $19.85
Prev. close $2.19 52-week low $2.07
Day low $2.15 Volume 289,500
Day high $2.31 Avg. volume 579,837
50-day MA $2.47 Dividend yield N/A
200-day MA $5.86 Market Cap 88.66M

TCR2 Therapeutics Inc. (TCRR) Company Bio


TCR2 Therapeutics, Inc. is an immunotherapy company, which develops biological drugs and engineering T-cells for cancer therapy. The company offers cancer therapy, T-cell biology, Immunology and Molecular biology. It also engages in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded in May 2015 and is headquartered in Cambridge, MA.


TCRR Latest News Stream


Event/Time News Detail
Loading, please wait...

TCRR Latest Social Stream


Loading social stream, please wait...

View Full TCRR Social Stream

Latest TCRR News From Around the Web

Below are the latest news stories about Tcr2 Therapeutics Inc that investors may wish to consider to help them evaluate TCRR as an investment opportunity.

Tcr2 Therapeutics (TCRR) presents Interim Data from Ongoing Gavo-cel Phase 1/2 Clinical Trial

The following slide deck was published by TCR2 Therapeutics Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | NA NA, NA

TCR2 Therapeutics (TCRR) Investor Presentation

The following slide deck was published by TCR2 Therapeutics Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | NA NA, NA

Read More 'TCRR' Stories Here

TCRR Price Returns

1-mo 7.98%
3-mo -15.13%
6-mo -55.34%
1-year -87.99%
3-year -84.25%
5-year N/A
YTD -50.64%
2021 -84.93%
2020 116.60%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4184 seconds.